Bryan, TX, United States of America

Peter Kipp

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ibio Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Kipp. Retrieved from https://idiyas.com/inventor/peter-kipp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Peter Kipp

Introduction

Peter Kipp is an accomplished inventor based in Bryan, TX (US). He has made significant contributions to the field of cancer treatment through his innovative work. His expertise lies in the development of antibodies that target specific cancer cells, providing new avenues for therapeutic interventions.

Latest Patents

Peter Kipp holds a patent for an Anti-CD-25 antibody. This patent encompasses materials and methods for using polypeptides containing fragments and variants of the antibody that bind CD25. The invention aims to treat cancer either alone or in combination with other anti-neoplastic agents. This groundbreaking work has the potential to enhance cancer treatment protocols significantly.

Career Highlights

Kipp is associated with iBio Limited, a company focused on advancing biopharmaceuticals. His role at the company allows him to leverage his expertise in antibody development to contribute to innovative cancer therapies. His work is pivotal in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes.

Collaborations

Peter Kipp collaborates with talented individuals such as Dillon Phan and Tam Phuong. These partnerships enhance the research and development efforts at iBio Limited, fostering an environment of innovation and creativity.

Conclusion

Peter Kipp's contributions to cancer treatment through his patented Anti-CD-25 antibody exemplify the impact of innovative thinking in medicine. His work at iBio Limited and collaborations with fellow researchers highlight the importance of teamwork in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…